OraSure Technologies to Present at the Raymond James 35th Annual Institutional Investors Conference

OraSure Technologies to Present at the Raymond James 35th Annual Institutional Investors Conference  BETHLEHEM, Pa., Feb. 24, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Raymond James 35^th Annual Institutional Investors Conference in Orlando, Florida. The conference will be simultaneously webcast over the Internet.  Mr. Michels is scheduled to speak March 3, 2014, at approximately 8:40 am Eastern Time (5:40 am Pacific Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies' web site, www.orasure.com, and clicking on the Investor Info link.A replay of the webcast will be available on OraSure Technologies' web site for seven days.Alternatively, you can access the live webcast of the presentation via the following link http://www.com/webcast/rj89/osur.  About OraSure Technologies  OraSure Technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its innovative products include rapid tests for the detection of antibodies to HIV and HCV at the point of care and testing solutions for detecting various drugs of abuse. The Company sells the OraQuick® In-Home HIV Test, the first and only rapid HIV test approved by the U.S. Food and Drug Administration for sale to the consumer over-the-counter market in the U.S. In addition, the Company is a leading provider of oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, and commercial and industrial entities. The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health.  For more information on the Company, please go to www.orasure.com.  CONTACT: Ronald H. Spair          Chief Financial Officer          610-882-1820          Investorinfo@orasure.com          www.orasure.com  company logo